25 XP   0   0   10

Assembly Biosciences Inc
Buy, Hold or Sell?

Let's analyze Assembly Biosciences Inc together

I guess you are interested in Assembly Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Assembly Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Assembly Biosciences Inc

I send you an email if I find something interesting about Assembly Biosciences Inc.

Quick analysis of Assembly Biosciences Inc (30 sec.)










What can you expect buying and holding a share of Assembly Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$5.91
Expected worth in 1 year
$-0.93
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-6.84
Return On Investment
-56.3%

For what price can you sell your share?

Current Price per Share
$12.15
Expected price per share
$10.36 - $14.28
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Assembly Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)

$12.15

Intrinsic Value Per Share

$-126.35 - $-55.99

Total Value Per Share

$-120.44 - $-50.08

2. Growth of Assembly Biosciences Inc (5 min.)




Is Assembly Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$32.6m$94.8m-$52.2m-122.7%

How much money is Assembly Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$12.8m-$21.8m$8.9m69.8%
Net Profit Margin-77.5%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Assembly Biosciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#487 / 966

Most Revenue
#389 / 966

Most Profit
#611 / 966

Most Efficient
#447 / 966
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Assembly Biosciences Inc? (5 min.)

Welcome investor! Assembly Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Assembly Biosciences Inc.

What can you expect buying and holding a share of Assembly Biosciences Inc?

First you should know what it really means to hold a share of Assembly Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Assembly Biosciences Inc is $12.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Assembly Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Assembly Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $5.91. Based on the TTM, the Book Value Change Per Share is $-1.71 per quarter. Based on the YOY, the Book Value Change Per Share is $2.43 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Assembly Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.65-13.6%-2.33-19.2%-2.12-17.5%-1.27-10.4%-0.99-8.2%
Usd Book Value Change Per Share-1.54-12.7%-1.71-14.1%2.4320.0%-0.08-0.6%0.050.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.54-12.7%-1.71-14.1%2.4320.0%-0.08-0.6%0.050.4%
Usd Price Per Share13.30-4.04-1.47-7.14-13.34-
Price to Earnings Ratio-2.02--0.58--0.51--2.27--5.92-
Price-to-Total Gains Ratio-8.63--4.18--2.06--84.06--52.52-
Price to Book Ratio2.25-0.65-0.44-1.13-2.49-
Price-to-Total Gains Ratio-8.63--4.18--2.06--84.06--52.52-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share12.15
Number of shares82
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.71-0.08
Usd Total Gains Per Share-1.71-0.08
Gains per Quarter (82 shares)-140.30-6.17
Gains per Year (82 shares)-561.19-24.67
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-561-5710-25-35
20-1122-11320-49-60
30-1684-16930-74-85
40-2245-22540-99-110
50-2806-28150-123-135
60-3367-33760-148-160
70-3928-39370-173-185
80-4490-44980-197-210
90-5051-50590-222-235
100-5612-56200-247-260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%1.039.00.02.5%1.060.01.01.6%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%4.016.00.020.0%8.032.00.020.0%11.047.04.017.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.062.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%4.016.00.020.0%8.032.00.020.0%11.047.04.017.7%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Assembly Biosciences Inc

About Assembly Biosciences Inc

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. It develops ABI-5366, a long-acting herpes simplex virus (HSV) helicase-primase inhibitor that is in Phase 1a/1b clinical trial to treat recurrent genital herpes; ABI-1179, which is in Phase 1a/1b clinical trial for the treatment of recurrent genital herpes; and ABI-6250, a small molecule orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical trial. The company also develops ABI-4334, a next-generation capsid assembly modulator, which is in Phase 1b clinical trial for the treatment of hepatitis B virus (HBV). In addition, it develops an oral non-nucleoside polymerase inhibitor targeting transplant-related herpesviruses; and a small molecule interferon-a receptor agonist targeting HBV and HDV. The company has collaboration agreements with Gilead Sciences, Inc. and BeiGene, Ltd. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Fundamental data was last updated by Penke on 2024-06-17 14:33:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Assembly Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Assembly Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Assembly Biosciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -156.9% means that $-1.57 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Assembly Biosciences Inc:

  • The MRQ is -156.9%. The company is making a huge loss. -2
  • The TTM is -77.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-156.9%TTM-77.5%-79.4%
TTM-77.5%YOY--77.5%
TTM-77.5%5Y-340.8%+263.3%
5Y-340.8%10Y-329.2%-11.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-156.9%-168.0%+11.1%
TTM-77.5%-209.9%+132.4%
YOY--242.3%+242.3%
5Y-340.8%-401.7%+60.9%
10Y-329.2%-532.2%+203.0%
1.1.2. Return on Assets

Shows how efficient Assembly Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Assembly Biosciences Inc to the Biotechnology industry mean.
  • -7.6% Return on Assets means that Assembly Biosciences Inc generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Assembly Biosciences Inc:

  • The MRQ is -7.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -17.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.6%TTM-17.2%+9.6%
TTM-17.2%YOY-19.8%+2.6%
TTM-17.2%5Y-13.4%-3.8%
5Y-13.4%10Y-11.4%-1.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.6%-11.9%+4.3%
TTM-17.2%-11.9%-5.3%
YOY-19.8%-11.3%-8.5%
5Y-13.4%-13.5%+0.1%
10Y-11.4%-14.9%+3.5%
1.1.3. Return on Equity

Shows how efficient Assembly Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Assembly Biosciences Inc to the Biotechnology industry mean.
  • -27.8% Return on Equity means Assembly Biosciences Inc generated $-0.28 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Assembly Biosciences Inc:

  • The MRQ is -27.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -30.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.8%TTM-30.0%+2.1%
TTM-30.0%YOY-23.6%-6.4%
TTM-30.0%5Y-17.8%-12.1%
5Y-17.8%10Y-15.7%-2.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.8%-14.2%-13.6%
TTM-30.0%-15.7%-14.3%
YOY-23.6%-14.3%-9.3%
5Y-17.8%-19.2%+1.4%
10Y-15.7%-19.7%+4.0%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Assembly Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Assembly Biosciences Inc is operating .

  • Measures how much profit Assembly Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Assembly Biosciences Inc to the Biotechnology industry mean.
  • An Operating Margin of -185.5% means the company generated $-1.85  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Assembly Biosciences Inc:

  • The MRQ is -185.5%. The company is operating very inefficient. -2
  • The TTM is -90.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-185.5%TTM-90.2%-95.3%
TTM-90.2%YOY--90.2%
TTM-90.2%5Y-350.9%+260.7%
5Y-350.9%10Y-342.4%-8.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-185.5%-354.6%+169.1%
TTM-90.2%-225.9%+135.7%
YOY--252.2%+252.2%
5Y-350.9%-428.3%+77.4%
10Y-342.4%-531.1%+188.7%
1.2.2. Operating Ratio

Measures how efficient Assembly Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.85 means that the operating costs are $2.85 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Assembly Biosciences Inc:

  • The MRQ is 2.855. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.402. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.855TTM1.402+1.453
TTM1.402YOY-+1.402
TTM1.4025Y6.650-5.248
5Y6.65010Y6.568+0.082
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8553.004-0.149
TTM1.4023.332-1.930
YOY-3.502-3.502
5Y6.6505.271+1.379
10Y6.5686.915-0.347
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Assembly Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Assembly Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.02 means the company has $3.02 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Assembly Biosciences Inc:

  • The MRQ is 3.023. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.164. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.023TTM5.164-2.140
TTM5.164YOY7.425-2.261
TTM5.1645Y9.645-4.481
5Y9.64510Y12.561-2.916
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0233.767-0.744
TTM5.1644.000+1.164
YOY7.4254.905+2.520
5Y9.6455.883+3.762
10Y12.5616.286+6.275
1.3.2. Quick Ratio

Measures if Assembly Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Assembly Biosciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 5.36 means the company can pay off $5.36 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Assembly Biosciences Inc:

  • The MRQ is 5.356. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.967. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.356TTM7.967-2.611
TTM7.967YOY10.449-2.482
TTM7.9675Y15.428-7.461
5Y15.42810Y17.856-2.428
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.3563.054+2.302
TTM7.9673.506+4.461
YOY10.4494.756+5.693
5Y15.4285.757+9.671
10Y17.8566.338+11.518
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Assembly Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Assembly Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Assembly Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.73 means that Assembly Biosciences Inc assets are financed with 72.8% credit (debt) and the remaining percentage (100% - 72.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Assembly Biosciences Inc:

  • The MRQ is 0.728. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.449. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.728TTM0.449+0.279
TTM0.449YOY0.159+0.290
TTM0.4495Y0.215+0.234
5Y0.21510Y0.228-0.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7280.330+0.398
TTM0.4490.342+0.107
YOY0.1590.287-0.128
5Y0.2150.368-0.153
10Y0.2280.382-0.154
1.4.2. Debt to Equity Ratio

Measures if Assembly Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Assembly Biosciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 267.7% means that company has $2.68 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Assembly Biosciences Inc:

  • The MRQ is 2.677. The company is unable to pay all its debts with equity. -1
  • The TTM is 1.368. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ2.677TTM1.368+1.309
TTM1.368YOY0.189+1.179
TTM1.3685Y0.427+0.941
5Y0.42710Y0.408+0.019
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6770.365+2.312
TTM1.3680.415+0.953
YOY0.1890.370-0.181
5Y0.4270.443-0.016
10Y0.4080.476-0.068
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Assembly Biosciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Assembly Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Assembly Biosciences Inc to the Biotechnology industry mean.
  • A PE ratio of -2.02 means the investor is paying $-2.02 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Assembly Biosciences Inc:

  • The EOD is -1.845. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.020. Based on the earnings, the company is expensive. -2
  • The TTM is -0.575. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.845MRQ-2.020+0.175
MRQ-2.020TTM-0.575-1.444
TTM-0.575YOY-0.509-0.066
TTM-0.5755Y-2.267+1.691
5Y-2.26710Y-5.920+3.654
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.845-2.341+0.496
MRQ-2.020-2.997+0.977
TTM-0.575-2.882+2.307
YOY-0.509-3.553+3.044
5Y-2.267-6.262+3.995
10Y-5.920-6.288+0.368
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Assembly Biosciences Inc:

  • The EOD is -0.911. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.997. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.296. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.911MRQ-0.997+0.086
MRQ-0.997TTM-0.296-0.701
TTM-0.296YOY-0.639+0.343
TTM-0.2965Y-1.523+1.226
5Y-1.52310Y-4.858+3.336
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.911-2.932+2.021
MRQ-0.997-3.739+2.742
TTM-0.296-3.776+3.480
YOY-0.639-4.917+4.278
5Y-1.523-7.942+6.419
10Y-4.858-8.503+3.645
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Assembly Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.25 means the investor is paying $2.25 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Assembly Biosciences Inc:

  • The EOD is 2.055. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.249. Based on the equity, the company is underpriced. +1
  • The TTM is 0.648. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD2.055MRQ2.249-0.194
MRQ2.249TTM0.648+1.601
TTM0.648YOY0.437+0.211
TTM0.6485Y1.126-0.478
5Y1.12610Y2.491-1.365
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.0551.843+0.212
MRQ2.2492.249+0.000
TTM0.6482.301-1.653
YOY0.4372.412-1.975
5Y1.1263.782-2.656
10Y2.4914.212-1.721
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Assembly Biosciences Inc.

3.1. Institutions holding Assembly Biosciences Inc

Institutions are holding 11.766% of the shares of Assembly Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Vanguard Group Inc3.58160.00011963681963680
2024-03-31Millennium Management LLC2.27850.00071249221249220
2023-12-31Franklin Resources Inc0.099406539200
2023-12-31HRT FINANCIAL LLC0.04640.000230518305180
2024-03-31Federated Hermes Inc0.46320.00082539400
2023-12-31UBS Group AG0.0367024164241640
2023-12-31Bank of New York Mellon Corp0.024101586600
2024-03-31Bridgeway Capital Management, LLC0.26450.003914500145000
2024-03-31Marquette Asset Management Inc.0.16440.0208901690160
2024-03-31Acadian Asset Management LLC0.1070.0003586858680
2023-12-31Rhumbline Advisers0.00370240200
2023-12-31Wells Fargo & Co0.0008050612231.7708
2023-12-31SIMPLEX TRADING, LLC0.0001073730
2023-12-31BakerAvenue Asset Management, LP000-1000-100
2023-12-31Hudson Bay Capital Management LP000-399578-100
2024-03-31HSBC Holdings PLC000-951-100
2023-12-31Advisor Group Holdings, Inc.000-500-100
2023-12-31SATTER MANAGEMENT CO., L.P.000-2227500-100
2024-03-31Charles Schwab Investment Management Inc000-2704-100
2024-03-31Palumbo Wealth Management LLC000-840-100
Total 7.07040.0268514989-2227522-432.5%

3.2. Funds holding Assembly Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-04-30Vanguard Total Stock Mkt Idx Inv2.08190.000111478200
2023-09-30BlackRock Extended Mkt Composite0.10450.00046916500
2024-04-30Vanguard Institutional Extnd Mkt Idx Tr1.20360.00086635640906.5686
2024-04-30Fidelity Extended Market Index0.55160.00130409-276-0.8995
2024-03-31Federated Hermes MDT Small Cap Growth IS0.46060.06972539400
2024-03-31Federated Hermes MDT SCG Institutional0.46060.06972539400
2024-03-31Vanguard Strategic Small-Cap Equity Inv0.32150.01461772310.0056
2024-03-31Bridgeway Ultra-Small Company Market0.24940.09491375010.0073
2023-12-31SSgA U.S. Extended Market Index Class I0.01860.00041233300
2024-04-30Fidelity Total Market Index0.1570.0001865500
2024-05-31Fidelity Enhanced Small Cap ETF0.14880.0215820600
2024-05-30iShares Micro-Cap ETF0.14640.01428069-112-1.369
2024-04-30SG Actions US Techno C0.14390.0155793400
2024-04-30Fidelity Series Total Market Index0.10270.0001566000
2024-03-31NT Ext Equity Mkt Idx Fd - NL0.09330.0015144193460.2492
2024-03-31Northern Trust Extended Eq Market Idx0.09140.00115041-1-0.0198
2024-03-31NT Ext Equity Mkt Idx Fd - L0.09140.00115041-1-0.0198
2024-03-31BlackRock Extended Equity Market K0.09120.0005503010.0199
2023-12-31NT US Market Cap Idx Fd - L0.00650.0001426900
2024-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0750.0014134155660.3569
Total 6.59990.3078442489+7193+1.6%

3.3. Insider Transactions

Insiders are holding 33.011% of the shares of Assembly Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-05-23Jason A OkazakiSELL54914.93
2024-05-23Jeanette M BjorkquistSELL2414.93
2024-05-23John G MchutchisonSELL211714.93
2024-04-30Jason A OkazakiSELL156912.71
2024-04-30Nicole S WhiteSELL125512.71
2024-04-01Jason A OkazakiSELL35413.07
2024-04-01Jeanette M BjorkquistSELL11413.07
2024-04-01John G MchutchisonSELL120613.07
2024-03-27Jason A OkazakiSELL39212.87
2024-01-17Alexander SchornsteinBUY249999.36
2023-10-03Jason A OkazakiSELL1969.6
2023-10-03Nicole S WhiteSELL1579.6
2023-07-24Jeanette M BjorkquistSELL7012.84
3rd party ad coffee SUPPORTERis ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Assembly Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.541-1.711+11%2.427-164%-0.075-95%0.046-3445%
Book Value Per Share--5.9137.725-23%8.108-27%6.765-13%6.367-7%
Current Ratio--3.0235.164-41%7.425-59%9.645-69%12.561-76%
Debt To Asset Ratio--0.7280.449+62%0.159+359%0.215+239%0.228+219%
Debt To Equity Ratio--2.6771.368+96%0.189+1315%0.427+527%0.408+556%
Dividend Per Share----0%-0%-0%-0%
Eps---1.646-2.329+41%-2.121+29%-1.268-23%-0.991-40%
Free Cash Flow Per Share---3.3331.249-367%-2.135-36%-0.512-85%-0.461-86%
Free Cash Flow To Equity Per Share---3.3331.672-299%-1.910-43%-0.108-97%118.472-103%
Gross Profit Margin--1.0041.003+0%1.000+0%1.001+0%1.000+0%
Intrinsic Value_10Y_max---55.993--------
Intrinsic Value_10Y_min---126.355--------
Intrinsic Value_1Y_max---2.374--------
Intrinsic Value_1Y_min---3.704--------
Intrinsic Value_3Y_max---9.600--------
Intrinsic Value_3Y_min---18.953--------
Intrinsic Value_5Y_max---19.800--------
Intrinsic Value_5Y_min---42.661--------
Market Cap66986716.500-9%73327023.00022267018.595+229%48168100.646+52%226393166.755-68%302706777.084-76%
Net Profit Margin---1.569-0.775-51%--100%-3.408+117%-3.292+110%
Operating Margin---1.855-0.902-51%--100%-3.509+89%-3.424+85%
Operating Ratio--2.8551.402+104%-+100%6.650-57%6.568-57%
Pb Ratio2.055-9%2.2490.648+247%0.437+415%1.126+100%2.491-10%
Pe Ratio-1.845+9%-2.020-0.575-72%-0.509-75%-2.267+12%-5.920+193%
Price Per Share12.150-9%13.3004.039+229%1.470+805%7.140+86%13.3440%
Price To Free Cash Flow Ratio-0.911+9%-0.997-0.296-70%-0.639-36%-1.523+53%-4.858+387%
Price To Total Gains Ratio-7.885+9%-8.631-4.185-52%-2.060-76%-84.063+874%-52.524+509%
Quick Ratio--5.3567.967-33%10.449-49%15.428-65%17.856-70%
Return On Assets---0.076-0.172+127%-0.198+161%-0.134+77%-0.114+51%
Return On Equity---0.278-0.300+8%-0.236-15%-0.178-36%-0.157-44%
Total Gains Per Share---1.541-1.711+11%2.427-164%-0.075-95%0.046-3445%
Usd Book Value--32601000.00042590250.000-23%94845250.000-66%160178400.000-80%132891767.250-75%
Usd Book Value Change Per Share---1.541-1.711+11%2.427-164%-0.075-95%0.046-3445%
Usd Book Value Per Share--5.9137.725-23%8.108-27%6.765-13%6.367-7%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.646-2.329+41%-2.121+29%-1.268-23%-0.991-40%
Usd Free Cash Flow---18378000.0006884500.000-367%-20148250.000+10%-15121023.500-18%-11396733.675-38%
Usd Free Cash Flow Per Share---3.3331.249-367%-2.135-36%-0.512-85%-0.461-86%
Usd Free Cash Flow To Equity Per Share---3.3331.672-299%-1.910-43%-0.108-97%118.472-103%
Usd Market Cap66986716.500-9%73327023.00022267018.595+229%48168100.646+52%226393166.755-68%302706777.084-76%
Usd Price Per Share12.150-9%13.3004.039+229%1.470+805%7.140+86%13.3440%
Usd Profit---9077000.000-12838750.000+41%-21802000.000+140%-21208600.000+134%-16930445.625+87%
Usd Revenue--5785000.0003237000.000+79%-+100%5519200.000+5%3452293.750+68%
Usd Total Gains Per Share---1.541-1.711+11%2.427-164%-0.075-95%0.046-3445%
 EOD+3 -5MRQTTM+16 -18YOY+12 -225Y+9 -2510Y+10 -24

4.2. Fundamental Score

Let's check the fundamental score of Assembly Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.845
Price to Book Ratio (EOD)Between0-12.055
Net Profit Margin (MRQ)Greater than0-1.569
Operating Margin (MRQ)Greater than0-1.855
Quick Ratio (MRQ)Greater than15.356
Current Ratio (MRQ)Greater than13.023
Debt to Asset Ratio (MRQ)Less than10.728
Debt to Equity Ratio (MRQ)Less than12.677
Return on Equity (MRQ)Greater than0.15-0.278
Return on Assets (MRQ)Greater than0.05-0.076
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Assembly Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.949
Ma 20Greater thanMa 5014.755
Ma 50Greater thanMa 10014.272
Ma 100Greater thanMa 20013.605
OpenGreater thanClose12.600
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets119,883
Total Liabilities87,282
Total Stockholder Equity32,601
 As reported
Total Liabilities 87,282
Total Stockholder Equity+ 32,601
Total Assets = 119,883

Assets

Total Assets119,883
Total Current Assets117,168
Long-term Assets2,715
Total Current Assets
Cash And Cash Equivalents 18,749
Short-term Investments 94,227
Net Receivables 343
Other Current Assets 3,849
Total Current Assets  (as reported)117,168
Total Current Assets  (calculated)117,168
+/-0
Long-term Assets
Property Plant Equipment 2,403
Long-term Assets Other 312
Long-term Assets  (as reported)2,715
Long-term Assets  (calculated)2,715
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities38,753
Long-term Liabilities48,529
Total Stockholder Equity32,601
Total Current Liabilities
Short-term Debt 1,145
Accounts payable 727
Other Current Liabilities 4,110
Total Current Liabilities  (as reported)38,753
Total Current Liabilities  (calculated)5,982
+/- 32,771
Long-term Liabilities
Capital Lease Obligations 1,936
Long-term Liabilities  (as reported)48,529
Long-term Liabilities  (calculated)1,936
+/- 46,593
Total Stockholder Equity
Common Stock5
Retained Earnings -794,825
Accumulated Other Comprehensive Income -239
Other Stockholders Equity 827,660
Total Stockholder Equity (as reported)32,601
Total Stockholder Equity (calculated)32,601
+/-0
Other
Capital Stock5
Cash and Short Term Investments 112,976
Common Stock Shares Outstanding 5,483
Current Deferred Revenue32,771
Liabilities and Stockholders Equity 119,883
Net Debt -16,813
Net Invested Capital 32,601
Net Working Capital 78,415
Property Plant and Equipment Gross 2,403
Short Long Term Debt Total 1,936



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-31
> Total Assets 
870
0
0
0
166
1,425
1,156
579
14,617
14,617
11,524
53,388
37,046
31,390
29,010
23,679
20,556
37,103
33,677
32,365
27,132
23,904
21,755
60,394
71,225
138,347
144,707
139,654
133,744
124,454
117,206
109,127
98,119
134,284
122,775
112,313
169,303
156,021
142,418
282,977
268,045
259,247
241,511
223,345
339,907
313,310
294,801
306,306
283,254
278,903
262,136
248,973
191,060
162,730
143,447
121,516
101,794
83,116
66,577
51,629
137,469
119,883
119,883137,46951,62966,57783,116101,794121,516143,447162,730191,060248,973262,136278,903283,254306,306294,801313,310339,907223,345241,511259,247268,045282,977142,418156,021169,303112,313122,775134,28498,119109,127117,206124,454133,744139,654144,707138,34771,22560,39421,75523,90427,13232,36533,67737,10320,55623,67929,01031,39037,04653,38811,52414,61714,6175791,1561,425166000870
   > Total Current Assets 
0
0
0
0
84
1,069
655
275
14,590
14,590
11,466
53,379
37,038
31,383
29,001
23,671
20,549
37,097
33,667
32,358
27,125
23,896
21,748
18,080
29,216
96,338
71,333
66,503
68,368
59,089
64,103
59,255
53,575
92,222
77,669
68,652
123,119
113,226
97,529
239,873
222,502
200,806
183,460
165,322
282,780
256,752
235,088
246,387
224,493
221,634
205,558
188,219
154,204
130,777
124,294
115,078
96,967
79,744
64,081
49,672
133,787
117,168
117,168133,78749,67264,08179,74496,967115,078124,294130,777154,204188,219205,558221,634224,493246,387235,088256,752282,780165,322183,460200,806222,502239,87397,529113,226123,11968,65277,66992,22253,57559,25564,10359,08968,36866,50371,33396,33829,21618,08021,74823,89627,12532,35833,66737,09720,54923,67129,00131,38337,03853,37911,46614,59014,5902756551,069840000
       Cash And Cash Equivalents 
16
0
0
0
81
1,068
650
271
14,571
14,571
11,369
53,294
36,975
31,067
28,844
23,560
20,489
36,874
33,490
32,223
27,061
23,637
21,316
17,933
29,091
96,054
53,518
36,401
27,108
20,395
20,341
23,794
28,575
70,818
39,453
27,247
82,033
66,927
54,192
119,752
41,471
29,107
34,258
24,867
46,732
42,326
96,709
58,311
59,444
78,253
59,517
70,760
45,627
51,174
43,063
54,673
52,418
43,482
21,623
26,656
19,841
18,749
18,74919,84126,65621,62343,48252,41854,67343,06351,17445,62770,76059,51778,25359,44458,31196,70942,32646,73224,86734,25829,10741,471119,75254,19266,92782,03327,24739,45370,81828,57523,79420,34120,39527,10836,40153,51896,05429,09117,93321,31623,63727,06132,22333,49036,87420,48923,56028,84431,06736,97553,29411,36914,57114,5712716501,0688100016
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,209
29,396
40,557
37,928
43,205
34,851
24,388
20,105
36,124
39,053
37,914
42,232
38,480
114,188
176,609
164,429
139,553
132,070
227,311
206,803
130,005
179,630
156,969
136,631
139,560
110,142
101,000
71,826
73,626
53,978
39,192
29,534
38,208
19,554
110,406
94,227
94,227110,40619,55438,20829,53439,19253,97873,62671,826101,000110,142139,560136,631156,969179,630130,005206,803227,311132,070139,553164,429176,609114,18838,48042,23237,91439,05336,12420,10524,38834,85143,20537,92840,55729,39617,20900000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
260
0
0
0
0
0
0
0
0
0
0
0
1,114
1,400
2,273
2,264
2,126
2,590
2,430
2,987
2,903
2,944
3,374
3,055
3,315
3,590
1,230
203
297
769
336
524
523
1,246
944
717
342
100
43
343
343431003427179441,2465235243367692972031,2303,5903,3153,0553,3742,9442,9032,9872,4302,5902,1262,2642,2731,4001,114000000000002600000000000000000000000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-100
0
0
00-10000000000000000000000000000000000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
82
356
501
304
27
27
58
9
8
7
9
8
7
6
9
8
7
8
7
42,314
42,009
42,009
73,374
73,151
65,376
65,365
53,103
49,872
44,544
42,063
45,106
43,661
46,185
42,795
44,889
43,104
45,543
58,441
58,051
58,023
57,127
56,558
59,713
59,919
58,761
57,269
56,578
60,754
36,856
31,953
19,153
6,438
4,827
3,372
2,496
1,957
3,682
2,715
2,7153,6821,9572,4963,3724,8276,43819,15331,95336,85660,75456,57857,26958,76159,91959,71356,55857,12758,02358,05158,44145,54343,10444,88942,79546,18543,66145,10642,06344,54449,87253,10365,36565,37673,15173,37442,00942,00942,314787896789789582727304501356820000
       Property Plant Equipment 
17
0
0
0
13
11
10
9
0
11
10
9
8
7
9
8
7
6
9
8
7
8
7
34
156
173
174
156
149
132
114
128
215
183
132
593
860
732
640
516
557
15,142
14,720
14,714
13,805
13,259
12,843
12,301
10,731
9,597
8,847
8,014
7,181
6,319
5,610
4,825
3,938
3,038
2,164
1,405
2,724
2,403
2,4032,7241,4052,1643,0383,9384,8255,6106,3197,1818,0148,8479,59710,73112,30112,84313,25913,80514,71414,72015,1425575166407328605931321832151281141321491561741731563478789678978910110910111300017
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,143
12,737
12,737
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
12,638
0
0
0
0
0
0
0
0
0
0
000000000012,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,63812,73712,73712,14300000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31,437
31,186
23,392
23,390
11,167
7,900
2,436
0
0
0
3,347
0
2,204
0
0
0
0
0
0
0
0
0
0
0
0
9,180
27,972
23,459
11,908
0
0
0
0
0
0
0
000000011,90823,45927,9729,1800000000000002,20403,3470002,4367,90011,16723,39023,39231,18631,43700000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,137
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
29,000
0
0
0
0
0
0
0
0
0
0
000000000029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00029,00030,13700000000000000000000000
       Long-term Assets Other 
0
0
0
0
70
345
491
295
27
27
48
0
0
0
0
0
0
0
0
0
0
0
0
0
115
99
125
170
197
204
184
205
255
242
327
426
340
426
407
951
3,348
1,661
1,693
1,671
1,684
1,661
5,232
5,980
6,392
6,034
6,093
1,922
158
2,175
1,635
1,613
78
334
332
552
312
312
312312552332334781,6131,6352,1751581,9226,0936,0346,3925,9805,2321,6611,6841,6711,6931,6613,348951407426340426327242255205184204197170125991150000000000000482727295491345700000
> Total Liabilities 
10,327
0
0
0
13,529
14,924
16,224
17,536
2,990
2,990
2,090
1,183
2,513
3,853
3,392
2,681
2,745
1,977
2,585
2,318
2,638
1,462
1,470
13,192
12,654
13,728
13,840
14,252
15,003
15,169
16,645
19,082
18,241
66,396
66,240
65,180
56,184
53,640
53,318
53,544
57,392
68,846
66,804
66,856
66,690
61,542
27,686
35,757
42,676
31,659
30,342
24,328
22,131
15,939
19,467
19,112
19,130
12,783
11,628
9,915
96,372
87,282
87,28296,3729,91511,62812,78319,13019,11219,46715,93922,13124,32830,34231,65942,67635,75727,68661,54266,69066,85666,80468,84657,39253,54453,31853,64056,18465,18066,24066,39618,24119,08216,64515,16915,00314,25213,84013,72812,65413,1921,4701,4622,6382,3182,5851,9772,7452,6813,3923,8532,5131,1832,0902,9902,99017,53616,22414,92413,52900010,327
   > Total Current Liabilities 
4,712
0
0
0
12,357
13,729
15,000
16,290
1,720
1,720
770
1,183
2,513
3,853
3,392
2,681
2,745
1,977
2,585
2,318
2,638
1,462
1,470
1,049
1,054
2,128
2,240
2,652
3,403
3,569
5,045
7,482
7,121
10,957
11,989
12,219
13,492
12,180
13,131
14,610
18,472
25,205
19,935
21,498
24,440
21,146
17,271
16,804
24,433
14,497
13,910
14,928
16,073
10,709
14,961
15,461
16,296
9,970
8,831
7,132
39,225
38,753
38,75339,2257,1328,8319,97016,29615,46114,96110,70916,07314,92813,91014,49724,43316,80417,27121,14624,44021,49819,93525,20518,47214,61013,13112,18013,49212,21911,98910,9577,1217,4825,0453,5693,4032,6522,2402,1281,0541,0491,4701,4622,6382,3182,5851,9772,7452,6813,3923,8532,5131,1837701,7201,72016,29015,00013,72912,3570004,712
       Short-term Debt 
0
0
0
0
7,841
10,199
10,688
7,426
1,219
1,219
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,704
2,854
3,208
3,186
3,264
3,250
3,338
3,404
2,934
3,048
3,099
3,151
3,207
3,311
3,371
3,364
2,546
1,702
869
1,220
1,145
1,1451,2208691,7022,5463,3643,3713,3113,2073,1513,0993,0482,9343,4043,3383,2503,2643,1863,2082,8542,70400000000000000000000000000000001,2191,2197,42610,68810,1997,8410000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,704
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000002,70400000000000000000000000000000000000000000
       Accounts payable 
4,125
0
0
0
3,362
2,136
1,676
1,282
313
313
622
1,183
2,342
3,143
3,158
1,843
1,847
1,527
2,132
2,280
2,615
1,435
1,421
1,049
908
1,251
1,304
1,464
1,364
2,326
2,414
3,838
2,368
1,947
688
871
2,124
2,373
2,539
2,988
3,693
2,427
3,414
2,709
1,731
2,104
3,640
1,611
4,598
3,562
2,866
2,628
2,659
1,407
2,454
1,942
2,493
1,224
904
758
461
727
7274617589041,2242,4931,9422,4541,4072,6592,6282,8663,5624,5981,6113,6402,1041,7312,7093,4142,4273,6932,9882,5392,3732,1248716881,9472,3683,8382,4142,3261,3641,4641,3041,2519081,0491,4211,4352,6152,2802,1321,5271,8471,8433,1583,1432,3421,1836223133131,2821,6762,1363,3620004,125
       Other Current Liabilities 
417
0
0
0
1,154
1,394
2,636
5,617
188
188
148
0
171
710
234
838
898
449
454
37
23
27
48
1,049
146
878
936
1,187
2,039
1,243
2,631
3,644
4,753
4,014
6,306
6,353
6,139
4,647
5,080
6,517
9,679
10,141
7,585
9,430
13,112
9,063
10,381
2,868
7,444
-986
-991
6,468
7,530
3,362
6,463
7,415
7,706
3,467
3,492
2,772
6,629
4,110
4,1106,6292,7723,4923,4677,7067,4156,4633,3627,5306,468-991-9867,4442,86810,3819,06313,1129,4307,58510,1419,6796,5175,0804,6476,1396,3536,3064,0144,7533,6442,6311,2432,0391,1879368781461,0494827233745444989883823471017101481881885,6172,6361,3941,154000417
   > Long-term Liabilities 
0
0
0
0
1,171
1,195
1,224
1,246
1,271
1,271
1,320
0
0
0
0
0
898,213
0
0
0
23,435
0
0
12,143
11,600
11,600
11,600
11,600
11,600
11,600
11,600
11,600
11,120
55,439
54,250
52,961
42,692
41,460
40,187
38,934
38,920
43,641
46,869
45,358
42,250
40,396
10,415
18,953
18,243
17,162
16,432
9,400
6,058
5,230
4,506
3,651
2,834
2,813
2,797
2,783
57,147
48,529
48,52957,1472,7832,7972,8132,8343,6514,5065,2306,0589,40016,43217,16218,24318,95310,41540,39642,25045,35846,86943,64138,92038,93440,18741,46042,69252,96154,25055,43911,12011,60011,60011,60011,60011,60011,60011,60011,60012,1430023,435000898,213000001,3201,2711,2711,2461,2241,1951,1710000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,600
0
0
0
11,600
0
0
0
11,120
44,319
43,075
41,815
40,555
41,460
40,187
38,934
38,920
33,120
36,834
35,519
33,168
31,857
2,531
11,518
11,518
11,518
11,518
5,264
2,733
2,733
2,733
2,733
0
0
2,733
0
0
0
0002,733002,7332,7332,7332,7335,26411,51811,51811,51811,5182,53131,85733,16835,51936,83433,12038,92038,93440,18741,46040,55541,81543,07544,31911,12000011,60000011,600000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,600
11,600
11,600
0
55,439
54,250
52,961
0
41,460
40,187
38,934
38,920
0
36,834
3,251
2,531
2,531
2,531
2,531
2,531
2,531
800
2,531
200
200
200
200
0
0
200
0
0
0
000200002002002002002,5318002,5312,5312,5312,5312,5312,5313,25136,834038,92038,93440,18741,460052,96154,25055,439011,60011,60011,60000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
-13,363
-13,499
-15,068
-16,957
11,626
11,626
9,434
52,205
34,533
27,537
25,619
20,998
17,810
35,126
31,091
30,048
24,494
22,442
20,285
47,202
58,571
124,619
130,867
125,402
118,742
109,285
100,561
90,045
79,878
67,888
56,535
47,133
113,120
102,381
89,101
229,433
210,653
190,401
174,707
156,489
273,217
251,768
267,115
270,549
240,578
247,244
231,794
224,645
168,929
146,791
123,980
102,404
82,664
70,333
54,949
41,714
41,097
32,601
32,60141,09741,71454,94970,33382,664102,404123,980146,791168,929224,645231,794247,244240,578270,549267,115251,768273,217156,489174,707190,401210,653229,43389,101102,381113,12047,13356,53567,88879,87890,045100,561109,285118,742125,402130,867124,61958,57147,20220,28522,44224,49430,04831,09135,12617,81020,99825,61927,53734,53352,2059,43411,62611,626-16,957-15,068-13,499-13,3630000
   Common Stock
0
0
0
0
0
6
6
0
7
7
7
12
12
12
13
13
13
20
20
21
21
23
5
9
11
16
17
17
17
17
17
17
17
17
17
17
20
20
21
25
25
26
26
26
32
32
33
33
34
40
44
47
48
48
48
48
49
52
52
53
5
5
5553525249484848484744403433333232262626252521202017171717171717171717161195232121202013131312121277706600000
   Retained Earnings Total Equity0000-743,470-724,520-702,125-678,980-654,5190-571,171-552,368-528,773-501,573-462,155-458,806-466,076-439,421-412,337-387,342-368,839-341,787-315,626-294,091-267,285-251,036-248,029-235,757-222,158-208,227-196,681-185,107-174,954-163,966-156,218-149,600-142,657-135,512-129,283-118,262-115,793-111,723-105,676-100,794-96,043-92,320-88,528-83,173-75,703-67,529-48,670-42,8680000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-15
0
0
0
-27
-27
0
0
-28
-28
0
0
-33
0
369
369
-39
369
369
369
0
-64
-134
-388
-822
-749
-839
-837
-601
-525
-398
-388
-392
-459
-372
-355
-347
-239
-187
-205
-201
-86
104
-158
-270
-271
-273
-288
-419
-908
-998
-999
-803
-513
-325
-275
-81
-239
-239-81-275-325-513-803-999-998-908-419-288-273-271-270-158104-86-201-205-187-239-347-355-372-459-392-388-398-525-601-837-839-749-822-388-134-640369369369-393693690-3300-28-2800-27-27000-150000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
52,295
100,862
102,049
103,228
108,779
109,514
110,117
131,149
131,497
135,334
135,828
137,843
138,174
176,108
194,073
267,260
280,584
281,991
283,512
284,972
286,490
287,545
288,689
290,554
292,673
295,533
364,528
370,105
383,543
545,389
552,762
559,453
562,210
569,005
712,807
717,898
725,784
732,829
742,387
776,248
784,391
796,057
0
802,170
803,910
805,480
807,938
814,264
0
0
0
0
0000814,264807,938805,480803,910802,1700796,057784,391776,248742,387732,829725,784717,898712,807569,005562,210559,453552,762545,389383,543370,105364,528295,533292,673290,554288,689287,545286,490284,972283,512281,991280,584267,260194,073176,108138,174137,843135,828135,334131,497131,149110,117109,514108,779103,228102,049100,86252,2950000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
4,545
6,410
6,969
6,861
44,831
44,831
52,295
100,862
102,078
103,228
108,779
109,514
110,150
131,149
131,497
135,334
136,236
137,843
138,174
176,108
194,073
267,324
280,584
281,991
283,512
284,972
286,490
287,545
288,689
290,554
292,673
295,533
364,528
370,105
383,543
545,389
552,762
559,453
562,210
569,005
712,807
717,898
725,784
732,829
742,387
776,248
784,391
796,057
800,728
802,170
803,910
805,480
807,938
814,264
815,588
816,722
826,921
827,660
827,660826,921816,722815,588814,264807,938805,480803,910802,170800,728796,057784,391776,248742,387732,829725,784717,898712,807569,005562,210559,453552,762545,389383,543370,105364,528295,533292,673290,554288,689287,545286,490284,972283,512281,991280,584267,324194,073176,108138,174137,843136,236135,334131,497131,149110,150109,514108,779103,228102,078100,86252,29544,83144,8316,8616,9696,4104,5450000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue7,163
Cost of Revenue-450
Gross Profit6,7136,713
 
Operating Income (+$)
Gross Profit6,713
Operating Expense-71,359
Operating Income-64,646-64,646
 
Operating Expense (+$)
Research Development48,900
Selling General Administrative22,909
Selling And Marketing Expenses450
Operating Expense71,35972,259
 
Net Interest Income (+$)
Interest Income2,412
Interest Expense-0
Other Finance Cost-0
Net Interest Income2,412
 
Pretax Income (+$)
Operating Income-64,646
Net Interest Income2,412
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-61,195-68,097
EBIT - interestExpense = -64,646
-61,195
-61,228
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-64,646-61,195
Earnings Before Interest and Taxes (EBITDA)-64,196
 
After tax Income (+$)
Income Before Tax-61,195
Tax Provision-33
Net Income From Continuing Ops-72,661-61,228
Net Income-61,228
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses71,809
Total Other Income/Expenses Net3,451-2,412
 

Technical Analysis of Assembly Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Assembly Biosciences Inc. The general trend of Assembly Biosciences Inc is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Assembly Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Assembly Biosciences Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 12.40 < 12.51 < 14.28.

The bearish price targets are: 12.00 > 11.60 > 10.36.

Tweet this
Assembly Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Assembly Biosciences Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Assembly Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Assembly Biosciences Inc. The current macd is -0.36086122.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Assembly Biosciences Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Assembly Biosciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Assembly Biosciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Assembly Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartAssembly Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Assembly Biosciences Inc. The current adx is 25.56.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Assembly Biosciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Assembly Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Assembly Biosciences Inc. The current sar is 15.61.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Assembly Biosciences Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Assembly Biosciences Inc. The current rsi is 29.95. The current phase is Oversold in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bull market: Short-term excessive selling, potential for rebound. Consider buying at a perceived discount, watch for reversal signs. +1
  • Trending down: The RSI is trending down. -1
Assembly Biosciences Inc Daily Relative Strength Index (RSI) ChartAssembly Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Assembly Biosciences Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Assembly Biosciences Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Assembly Biosciences Inc Daily Stochastic Oscillator ChartAssembly Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Assembly Biosciences Inc. The current cci is -251.95046218.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Assembly Biosciences Inc Daily Commodity Channel Index (CCI) ChartAssembly Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Assembly Biosciences Inc. The current cmo is -54.5830811.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Assembly Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartAssembly Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Assembly Biosciences Inc. The current willr is -86.3574352.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Assembly Biosciences Inc Daily Williams %R ChartAssembly Biosciences Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Assembly Biosciences Inc.

Assembly Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Assembly Biosciences Inc. The current atr is 0.93825032.

Assembly Biosciences Inc Daily Average True Range (ATR) ChartAssembly Biosciences Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Assembly Biosciences Inc. The current obv is 5,309,998.

Assembly Biosciences Inc Daily On-Balance Volume (OBV) ChartAssembly Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Assembly Biosciences Inc. The current mfi is 33.27.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Assembly Biosciences Inc Daily Money Flow Index (MFI) ChartAssembly Biosciences Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Assembly Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-05-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-05-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-05-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-05-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-31STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-06-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-06-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Assembly Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Assembly Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.949
Ma 20Greater thanMa 5014.755
Ma 50Greater thanMa 10014.272
Ma 100Greater thanMa 20013.605
OpenGreater thanClose12.600
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Assembly Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Assembly Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Assembly Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Assembly Biosciences Inc

I send you an email if I find something interesting about Assembly Biosciences Inc.


Stay informed about Assembly Biosciences Inc.

Receive notifications about Assembly Biosciences Inc in your mailbox!